-
公开(公告)号:US20230062800A1
公开(公告)日:2023-03-02
申请号:US17855543
申请日:2022-06-30
Applicant: DENALI THERAPEUTICS INC.
Inventor: Tina GIESE , Gunasekaran KANNAN , Mihalis KARIOLIS , Cathal MAHON
Abstract: Provided herein are proteins, which are capable of being transported across the blood-brain barrier (BBB) and comprise sulfoglucosamine sulfohydrolase (SGSH) enzyme-Fc fusion polypeptides. Certain embodiments also provide methods of using such proteins to treat Sanfilippo syndrome A.
-
公开(公告)号:US20220184186A1
公开(公告)日:2022-06-16
申请号:US17600527
申请日:2020-04-03
Applicant: DENALI THERAPEUTICS INC.
Inventor: Dana ANDERSEN , Adam CATHERMAN , Tina GIESE , Gunasekaran KANNAN , Mihalis KARIOLIS , Cathal MAHON , Ankit PATEL
Abstract: Certain embodiments provide a pharmaceutical composition comprising: a protein molecule comprising an ERT enzyme-Fc fusion polypeptide and a modified Fc polypeptide; a buffer; an isotonicity agent; a surfactant; and a stabilizer; wherein the pH of the pharmaceutical composition is about 5.5 to 7.0, as well as methods of use thereof.
-
公开(公告)号:US20200277584A1
公开(公告)日:2020-09-03
申请号:US16649943
申请日:2018-10-01
Applicant: DENALI THERAPEUTICS INC.
Inventor: Giuseppe ASTARITA , Mark S. DENNIS , Jennifer A. GETZ , Anastasia HENRY , Mihalis KARIOLIS , Cathal MAHON , Adam P. SILVERMAN , Ankita SRIVASTAVA , Julie ULLMAN , Junhua WANG , Joy Yu ZUCHERO
Abstract: Provided herein are fusion proteins that comprise an enzyme replacement therapy enzyme and an Fc region, as well as methods of using such proteins to treat a lysosomal storage disorder. Methods for transporting agents across the blood-brain barrier are also provided herein.
-
-